Vivli, as part of the NIH Generalist Repository Ecosystem Initiative GREI, is delighted to be one of the repositories that researchers can use to request the data as part of the 2024 DataWorks! Prize. Of the GREI repositories, Vivli is the only one that focuses on sharing the data from completed clinical trials.
About the Eligible Studies on Vivli
Vivli is offering an array of 25 COVID-19 clinical trials that offer a unique and comprehensive exploration into the treatment and management of this disease.These landmark randomized controlled trials (RCTs) encompass a wide spectrum of pharmacological agents, including Losartan, Hydroxychloroquine, Azithromycin, Colchicine, and Nitazoxanide, targeting various stages and severities of the disease state. The trials cover diverse COVID populations, ranging from those with severe acute respiratory syndrome to hospitalized and non-hospitalized patients, as well as high-risk groups.
By engaging with these trial data (including the protocol, CRFs, raw data, data dictionary) researchers will contribute to the collective effort to combat the COVID-19 pandemic.
In total, there are 37 completed clinical trials on Vivli that are eligible studies for the DataWorks! Prize.To find out more about the overall challenge, please go to the main challenge website.
